Triclabendazole

70 interactions 4 explained in plain English

Also sold as: Egaten Egaten®

About Triclabendazole

Triclabendazole is used to treat fascioliasis (an infection, usually in the liver and bile ducts, caused by flat worms [liver flukes]) in adults and children 6 years of age and older. Triclabendazole is in a class of medications called anthelmintics. It works by killing the flat worms. Read the full Triclabendazole drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jun 30, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Eribulin Injection Ivabradine Felbamate Ofloxacin Amisulpride Injection Obeticholic Acid

69 Major 1 Moderate

All (70) Major (69) Moderate (1)

Major

Triclabendazole Amitriptyline Elavil Explained An increased risk of QT interval prolongation Details Triclabendazole Sertraline Explained An increased risk of QT interval prolongation Details Triclabendazole Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Triclabendazole Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Triclabendazole Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Triclabendazole Arsenic Trioxide Trisenox An increased risk of QT interval prolongation Details Triclabendazole Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Triclabendazole Arsenic Trioxide Injection Trisenox An increased risk of QT interval prolongation Details Triclabendazole Asenapine Transdermal Patch Secuado An increased risk of QT interval prolongation Details Triclabendazole Azithromycin AzaSite An increased risk of QT interval prolongation Details Triclabendazole Alfuzosin UroXatral An increased risk of QT interval prolongation Details Triclabendazole Anagrelide Agrylin An increased risk of QT interval prolongation Details Triclabendazole Bedaquiline Sirturo An increased risk of QT interval prolongation Details Triclabendazole Chloroquine Aralen® An increased risk of QT interval prolongation Details Triclabendazole Dasatinib Phyrago An increased risk of QT interval prolongation Details Triclabendazole Degarelix Injection Firmagon An increased risk of QT interval prolongation Details Triclabendazole Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Triclabendazole Disopyramide Norpace An increased risk of QT interval prolongation Details Triclabendazole Dofetilide Tikosyn An increased risk of QT interval prolongation Details Triclabendazole Dolasetron Anzemet An increased risk of QT interval prolongation Details Triclabendazole Dolasetron Injection Anzemet An increased risk of QT interval prolongation Details Triclabendazole Encorafenib Braftovi An increased risk of QT interval prolongation Details Triclabendazole Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Triclabendazole Eribulin Injection Halaven An increased risk of QT interval prolongation Details Triclabendazole Famotidine Calmicid An increased risk of QT interval prolongation Details Triclabendazole Famotidine Injection Calmicid An increased risk of QT interval prolongation Details Triclabendazole Felbamate Felbatol An increased risk of QT interval prolongation Details Triclabendazole Flecainide Tambocor® An increased risk of QT interval prolongation Details Triclabendazole Foscarnet Injection Foscavir An increased risk of QT interval prolongation Details Triclabendazole Fostemsavir Rukobia Increased risk of torsade de pointes Details Triclabendazole Galantamine Razadyne An increased risk of QT interval prolongation Details Triclabendazole Gatifloxacin Ophthalmic Zymar® An increased risk of QT interval prolongation Details Triclabendazole Gemifloxacin Factive An increased risk of QT interval prolongation Details Triclabendazole Glasdegib Daurismo An increased risk of QT interval prolongation Details Triclabendazole Goserelin Implant Zoladex An increased risk of QT interval prolongation Details Triclabendazole Granisetron Transdermal Patch Sancuso An increased risk of QT interval prolongation Details Triclabendazole Granisetron Injection Granisol An increased risk of QT interval prolongation Details Triclabendazole Histrelin Implant Supprelin An increased risk of QT interval prolongation Details Triclabendazole Hydroxychloroquine Plaquenil An increased risk of QT interval prolongation Details Triclabendazole Inotuzumab Ozogamicin Injection Besponsa An increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.